ArticleJournal of cancer research and clinical oncology2023

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition.

Arthur Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.